This week on the BackTable Urology Podcast, Dr. Jose Silva invites Dr. Seth Bechis onto the show to discuss the diagnosis and treatment of BPH with Rezum, a minimally invasive surgical that uses water vapor to dissolve prostate tissue
Abstract Purpose of Review Rezum® is a novel convection-based thermal therapy for benign prostatic hyperplasia (BPH) induced lower urinary tract symptoms (LUTS). This review provides an overview of its safety, efficacy, cost, and potential role in the paradigm of BPH/LUTS therapies. Recent...
Introduction: The options for treating benign prostatic hyperplasia (BPH) beyond medication and traditional transurethral surgery continue to expand. Undesirable side effects to medication and surgeries have driven interest toward minimally invasive surgical therapies (MISTs), including...
Abstract Purpose Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH. Methods We prospectively followed 135 consecutive patients treated by Rezūm at 5...
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures (2023) Juan V.A. Franco,Pablo Tesolin, Jae Hung Jung Abstract Lower urinary tract symptoms due to benign prostatic hyperplasia constitute a substantial burden, affecting the quality of life...
New Technologies for Treatment of Benign Prostatic Hyperplasia (2021) Dean Elterman, MD, MS, FRCSC, Bruce Gao, MD, Steven Lub, Naeem Bhojani, MD, FRCSC, Kevin C. Zorn, MD, FRCSC, Bilal Chughtai, MD INTRODUCTION Benign prostatic hyperplasia (BPH) is a ubiquitous disease that affects 50% of...
There is a strong association between benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) and sexual dysfunction. While transurethral resection of the prostate (TURP) is considered the standard BPH treatment, it is however associated with a high rate of erectile and...
Abstract Purpose of Review To explore the sexual outcomes following the novel minimally invasive surgical procedures for benign prostatic hyperplasia- (BPH-) related lower urinary tract symptoms (LUTS), with an emphasis on ejaculatory dysfunction (EjD). Recent Findings A database search with...
Abstract Purpose To review and discuss the literature regarding iTIND, Urolift, and Rezūm and investigate the precise clinical indications of all three different approaches for their application in benign prostatic hyperplasia (BPH) treatment. Materials and methods The PubMed–Medline and...
An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model Abstract Objective This study was designed to provide an indirect comparison of the urinary and sexual domain outcomes and complications following newer minimally...
Abstract Interventional therapies (IT) are increasingly popular treatment options for benign prostatic hyperplasia (BPH). IT aim to reduce morbidity and side effects related to invasive surgical procedures. To date, IT are considered experimental, though they are evolving rapidly and starting...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.